Literature DB >> 3091600

Purification and characterization of 5'-deoxy-5'-methylthioadenosine phosphorylase from human placenta.

F Della Ragione, M Cartenì-Farina, V Gragnaniello, M I Schettino, V Zappia.   

Abstract

5'-Methylthioadenosine phosphorylase has been purified to homogeneity (30,000-fold) from human full-term placenta by a procedure involving covalent chromatography on organomercurial-agarose as the major step. The specific activity of the homogeneous enzyme is 10.2 mumol of 5'-methylthioadenosine cleaved per min per mg of protein, and the overall yield is about 20%. The enzyme has a molecular weight of 98,000, as determined by gel filtration on Sephacryl S-200 and Superose 6B, and is composed by three apparently identical subunits with a molecular weight of 32,500. The isoelectric point is 5.5, and the optimal pH ranges from 7.2 to 7.6. The resistance of the enzyme to thermal inactivation is increased remarkably by the addition of 5'-methylthioadenosine or phosphate. The homogeneous enzyme shows an absolute requirement for -SH-reducing agents and is specifically and rapidly inactivated by thiol-blocking compounds. The reaction catalyzed by the enzyme is fully reversible with a Keq of 1.39 X 10(-2) (in the direction of phosphorolysis) at 37 degrees C and pH 7.4. The Km values for 5'-methylthioadenosine, phosphate, adenine, and 5-methylthioribose 1-phosphate are 5, 320, 23, and 8 microM, respectively.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3091600

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Purification and characterization of 5'-methylthioadenosine phosphorylase from the hyperthermophilic archaeon Pyrococcus furiosus: substrate specificity and primary structure analysis.

Authors:  Giovanna Cacciapuoti; Costanzo Bertoldo; Assunta Brio; Vincenzo Zappia; Marina Porcelli
Journal:  Extremophiles       Date:  2003-01-10       Impact factor: 2.395

2.  Entropy-driven binding of picomolar transition state analogue inhibitors to human 5'-methylthioadenosine phosphorylase.

Authors:  Rong Guan; Meng-Chiao Ho; Michael Brenowitz; Peter C Tyler; Gary B Evans; Steven C Almo; Vern L Schramm
Journal:  Biochemistry       Date:  2011-11-07       Impact factor: 3.162

3.  Primate genome gain and loss: a bone dysplasia, muscular dystrophy, and bone cancer syndrome resulting from mutated retroviral-derived MTAP transcripts.

Authors:  Olga Camacho-Vanegas; Sandra Catalina Camacho; Jacob Till; Irene Miranda-Lorenzo; Esteban Terzo; Maria Celeste Ramirez; Vern Schramm; Grace Cordovano; Giles Watts; Sarju Mehta; Virginia Kimonis; Benjamin Hoch; Keith D Philibert; Carsten A Raabe; David F Bishop; Marc J Glucksman; John A Martignetti
Journal:  Am J Hum Genet       Date:  2012-03-29       Impact factor: 11.025

4.  Biosynthesis and metabolism of 9-[5'-deoxy-5'-(methylthio)-beta-D-xylofuranosyl]adenine, a novel natural analogue of methylthioadenosine.

Authors:  M Porcelli; G Cacciapuoti; G Cimino; M Gavagnin; G Sodano; V Zappia
Journal:  Biochem J       Date:  1989-11-01       Impact factor: 3.857

5.  Structural and biochemical basis for the inhibition of cell death by APIP, a methionine salvage enzyme.

Authors:  Wonchull Kang; Se Hoon Hong; Hye Min Lee; Na Yeon Kim; Yun Chan Lim; Le Thi My Le; Bitna Lim; Hyun Chul Kim; Tae Yeon Kim; Hiroki Ashida; Akiho Yokota; Sang Soo Hah; Keun Ho Chun; Yong-Keun Jung; Jin Kuk Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-23       Impact factor: 11.205

6.  Deficiency of 5'-deoxy-5'-methylthioadenosine phosphorylase activity in malignancy. Absence of the protein in human enzyme-deficient cell lines.

Authors:  F Della Ragione; A Oliva; R Palumbo; G L Russo; V Gragnaniello; V Zappia
Journal:  Biochem J       Date:  1992-01-15       Impact factor: 3.857

7.  Transition state analogue inhibitors of human methylthioadenosine phosphorylase and bacterial methylthioadenosine/S-adenosylhomocysteine nucleosidase incorporating acyclic ribooxacarbenium ion mimics.

Authors:  Keith Clinch; Gary B Evans; Richard F G Fröhlich; Shivali A Gulab; Jemy A Gutierrez; Jennifer M Mason; Vern L Schramm; Peter C Tyler; Anthony D Woolhouse
Journal:  Bioorg Med Chem       Date:  2012-07-14       Impact factor: 3.641

8.  Leishmania infantum 5'-Methylthioadenosine Phosphorylase presents relevant structural divergence to constitute a potential drug target.

Authors:  Hela Abid; Emna Harigua-Souiai; Thouraya Mejri; Mourad Barhoumi; Ikram Guizani
Journal:  BMC Struct Biol       Date:  2017-12-19

Review 9.  An Unanticipated Modulation of Cyclin-Dependent Kinase Inhibitors: The Role of Long Non-Coding RNAs.

Authors:  Debora Bencivenga; Emanuela Stampone; Angela Vastante; Myassar Barahmeh; Fulvio Della Ragione; Adriana Borriello
Journal:  Cells       Date:  2022-04-14       Impact factor: 7.666

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.